25 results
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:18pm
. The Board of Directors has determined that William Farley, Anthony Giovinazzo and Paul Van Damme each meet the independence requirements for directors … , including the heightened independence standards for members of the audit committee under Rule 10A-3 under the Exchange Act. The Board has determined
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:11pm
. The Board of Directors has determined that William Farley, Anthony Giovinazzo and Paul Van Damme each meet the independence requirements for directors … , including the heightened independence standards for members of the audit committee under Rule 10A-3 under the Exchange Act. The Board has determined
POS AM
EX-10.26
XRTX
XORTX Therapeutics Inc
4 Aug 23
Prospectus update (post-effective amendment)
4:05pm
parties shall retain their independence. The Contractor shall be and shall act solely as an independent contractor in the performance of its duties
6-K
EX-99.2
bowxao
30 May 23
Notice of Annual & Special Meeting of Shareholders
7:00am
6-K
EX-99.3
zki9a d8lrb
3 Apr 23
Consolidated Financial Statements
6:05am
424B4
wja8z1m1gpgg7ijkck
5 Oct 22
Prospectus supplement with pricing info
5:24pm
POS AM
6kr1gv38fjdbm
29 Sep 22
Prospectus update (post-effective amendment)
9:49pm
F-1/A
cxyoui4kq4m9nh68
21 Sep 22
Registration statement (foreign) (amended)
4:20pm
F-1
fcqr9414ji 4g5sn6
8 Sep 22
Registration statement (foreign)
1:02pm
DRS
sogf6hecsgj56u9xb sq
15 Aug 22
Draft registration statement
12:00am
6-K
EX-99.2
61nrh uh5jo30szv687
30 Jun 22
Notice of Annual & Special Meeting of Shareholders
6:00am
20-F
EX-15.2
ok2l8yy9nqwdzzwn
3 May 22
Annual report (foreign)
5:29pm
20-F
58yjj8 sr2mg33
3 May 22
Annual report (foreign)
5:29pm
6-K
EX-99.1
xat zlgbon7gvn8c7c
13 Apr 22
Current report (foreign)
7:23am
6-K
EX-99.2
kkmdd20m6dtrf
23 Nov 21
Notice of Annual & Special Meeting of Shareholders
7:17am
424B4
un3fd2ee
14 Oct 21
Prospectus supplement with pricing info
4:30pm